Where to buy Argireline.

Where to buy Argireline has three real answers. A research-supply vendor sells it as lyophilized powder by the milligram, and a cosmetic ingredient house sells it as bulk carrier solution by the kilogram. A drugstore sells it inside a finished serum. The same molecule sits in all three, and confusing them is the commonest Argireline sourcing mistake.

Research compounds

Referenced in this guide

Batch-matched COAHPLC + mass specResearch use only

Third-party tested research compounds, each shipped with a batch-matched certificate of analysis showing HPLC purity and mass-spec identity — the documentation this site argues you should hold any supplier to.

Browse the catalog

• CoA. Certificate of Analysis. A one-page lab report showing the specific lot's purity, identity, and net peptide content.
• ISO/IEC 17025. The international quality standard for testing labs. A 17025-accredited lab has been audited by a third party for technical competence.
• INCI. International Nomenclature of Cosmetic Ingredients. The naming registry for cosmetic raw materials. Argireline is listed there as acetyl hexapeptide-8, formerly acetyl hexapeptide-3.
• Lyophilized. Freeze-dried into a stable powder. Lyophilized peptides survive shipping at room temperature for short periods and store for years frozen.
• HPLC. High-performance liquid chromatography. The standard purity test for peptides. The chromatogram is the squiggly line that shows how clean the batch is.

Where can you buy Argireline?

Argireline sells through three channels that look similar and aren't. Research-supply vendors ship lyophilized powder with a per-lot certificate. Cosmetic ingredient houses ship dilute bulk solution with a spec sheet. Retailers ship finished serums with no peptide figure at all. Only the first is verifiable as a reference compound.

• Research-supply vendors. The channel this guide is about. Argireline arrives as lyophilized powder, measured in milligrams, labeled for laboratory research use only, with a per-lot Certificate of Analysis. Ask for mass-spec identity near 890.0, HPLC purity with the chromatogram, CAS 616204-22-9 on the identity line, and a tested rather than nominal mg-per-vial figure.
• The cosmetic raw-material channel. The supply chain Argireline was built for. Lubrizol and other ingredient houses sell acetyl hexapeptide-8 to formulators as bulk raw material, usually pre-dissolved in a water or carrier solution and priced per kilogram of solution. Documentation is a cosmetic-ingredient spec sheet, not a per-lot identity CoA.
• Finished cosmetics. Argireline's retail life. Serums and creams at 5–10% formulation concentration sell over the counter under cosmetic claims. Peptide content is almost never disclosed in milligrams and the matrix is proprietary, so no identity verification is possible.

Percentage figures in the cosmetic channel describe the stock solution by convention, not peptide mass. The actual peptide fraction can be a small share of what a label number suggests. That channel is legitimate and professionally run.

The hazard for a research buyer is downstream of it. Grey-market resellers repackage dilute cosmetic-grade solution into small vials and sell it beside research-grade powder at research-grade prices. Without a CoA stating mg of peptide, you can't tell which one you received.

Which vendors should be on your Argireline shortlist?

Naming a channel is not the same as naming a supplier. Of the 16 storefronts we checked on 13 August 2026, these six published the most, judged on the documents they make public rather than the claims they make. The columns describe the vendor and not its catalog, so check Argireline itself is stocked as lot-tested powder before ordering. Pricing across this set is benchmarked on BPC-157, the one compound all six carry; no Argireline price was verified here, so no price column appears.

Three vendors from the same survey are absent on purpose. Red Rock Peptides advertises “Verified With COAs” and publishes no certificate at all. Limitless Biotech gates every price behind an account, so nothing it offers can be compared against anything. Behemoth Labz does publish, but its newest genuine certificate is dated August 2024. The full ranking, with the price column, is in our comparison of peptide companies. Disclosure: this site earns a commission on purchases made through its links, Peptriva included — which is why every column above is a document you can open or a figure you can load for yourself.

On the certificate, Argireline should carry CAS 616204-22-9 and a molecular weight of 889.0 g/mol, with peptide content stated in milligrams — a bare percentage describes the carrier solution rather than the peptide.

What is Argireline?

Argireline is the trade name for acetyl hexapeptide-3, also registered under the newer INCI name acetyl hexapeptide-8. Both names mean one molecule. It's a six-residue synthetic peptide, sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂, formula C₃₄H₆₀N₁₄O₁₂S, molecular weight 889.0 g/mol.

Argireline was developed in the early 2000s by the Spanish biotech firm Lipotec, later acquired by Lubrizol, and introduced as a topical anti-wrinkle cosmetic ingredient.

The design rationale was to mimic the N-terminal binding domain of SNAP-25, the SNARE-complex protein that botulinum toxin cleaves enzymatically. The short peptide competitively interferes with SNARE assembly and reduces acetylcholine release. It does so reversibly and concentration-dependently, without the toxin's irreversible cleavage. See Blanes-Mira et al., 2002 and Megighian et al., 2015.

That mechanism is the whole basis of the “topical Botox” marketing. The honest version is narrower. The strongest independent controlled trial, vehicle-controlled in 60 subjects, reported roughly 16% wrinkle-parameter improvement over 84 days at 10% topical concentration, per Wang et al., 2013.

Real, statistically detectable, and nowhere near the 60–80%+ bracket reported for injectable botulinum toxin at treated sites. Our complete Argireline research guide has the full evidence picture.

The other honest limitation is delivery. The 500 Dalton rule bounds passive skin penetration for compounds well above 500 Da, per Bos and Meinardi, 2000. Argireline weighs 889 Da. So the delivery vehicle, not the pharmacology, is what binds a topical formulation.

A hyaluronic-acid microneedle patch that physically bypasses the stratum corneum produced roughly 27% wrinkle-parameter reduction at 8 weeks, meaningfully more than serum delivery. That's An et al., 2019. The compound's identity is the same in every format. The published effect sizes are not.

How do you verify Argireline before you buy?

Four checks are sharper for Argireline than for most peptides. Confirm the two INCI names are one product. Confirm the acetyl and amide caps by mass. Confirm peptide content in milligrams rather than percent. Discount any botulinum-equivalence claim. Our eight general criteria apply on top.

1. One molecule, two INCI names

Acetyl hexapeptide-3 and acetyl hexapeptide-8 are the same compound. The INCI registry shifted the designation and the sequence never changed. A vendor listing the two as separate products at separate prices either doesn't understand its own catalog or is padding it.

CAS Registry Number 616204-22-9 is the unambiguous identifier. It should appear on the CoA whichever trade or INCI name the label uses.

2. Acetylation and amidation identity

Argireline is capped at both ends. An acetyl group sits on the N-terminal glutamate and an amide on the C-terminal arginine. The acetyl cap alone adds 42 daltons.

The uncapped hexapeptide is a different molecule. Different mass, roughly 847 Da without the acetyl group, different stability, and not the compound validated in the published literature.

Mass spectrometry on the CoA should report observed mass near 890.0, within about 0.5 daltons of target. The peptide picks up one hydrogen during the test, which is what [M+H]⁺ means. A reading near 848 means the acetyl cap is missing. Any other significant mismatch means the vial doesn't hold Argireline.

3. Concentration and carrier verification

This check separates Argireline from most research peptides. Because the cosmetic channel sells the molecule as a dilute solution, percent claims are ambiguous by convention. A “10% Argireline” label on a liquid may describe 10% of a stock solution, not 10% peptide by mass.

Research material should be lyophilized powder with peptide content stated in milligrams on the CoA. If a vendor sells Argireline as a liquid, the CoA has to state measured peptide concentration in mg/mL and the carrier composition. A percentage with no mg figure anywhere isn't a specification. It's marketing.

4. The “topical Botox” claim check

The SNAP-25-mimetic mechanism is real and published: competitive, reversible interference with SNARE assembly, first characterized in chromaffin-cell models by Blanes-Mira et al., 2002.

Botulinum toxin's mechanism is enzymatic and irreversible. It cleaves SNAP-25 rather than competing with it, per Megighian et al., 2015.

A vendor page leaning on “works like Botox” is blurring a competitive inhibitor into a proteolytic knockout. It's also blurring a 10–27% published effect range into a 60–80%+ one. In our experience, vendors who describe the mechanism accurately are the same vendors whose CoAs hold up.

What does Argireline cost in 2026?

Argireline runs $25–$55 for a 10 mg research vial and $60–$110 for 50 mg. It's one of the cheapest peptides on the research market to synthesize: six residues, two simple caps, and an industrial global supply chain built for cosmetics. That keeps pricing low and makes expensive Argireline its own red flag.

• 10 mg vial: $25–$55, or $2.50–$5.50 per mg. The standard research size.
• 50 mg vial: $60–$110, or $1.20–$2.20 per mg. Common for formulation-development work, where 5–10% w/w use levels consume material quickly.
• 100 mg and bulk: below $1.50 per mg, trending toward cosmetic-ingredient economics. At this scale, check the material is still lot-tested peptide powder rather than repackaged ingredient solution.
• Multi-vial discounts: 10–25% off on 3-packs and 6-packs at most vendors.

Pricing meaningfully below $15 per 10 mg vial deserves a question. At that level the likeliest explanations are skipped HPLC purification, cosmetic-solution repackaging, or an untested nominal fill mass.

Above roughly $8/mg, you're paying retail markup rather than synthesis cost. Nothing about a six-residue peptide with an industrial supply chain justifies boutique pricing.

Is Argireline legal to buy?

Yes. Argireline is regulated as a cosmetic ingredient rather than a drug, which gives it something most research peptides don't have: a fully legal consumer channel alongside the research one.

• United States, FDA: Not a drug. Regulated as a cosmetic ingredient, and finished products sell over the counter under cosmetic claims such as “reduces the appearance of expression lines”. Raw peptide sells legally as a research reference compound labeled for laboratory use only. Not a controlled substance.
• European Union: Cosmetic ingredient, under Lubrizol's INCI registration as acetyl hexapeptide-8.
• UK MHRA, Canada, Australia TGA: Cosmetic ingredient.
• WADA: Not listed, not a banned substance. See the WADA Prohibited List for current categorizations.

The boundary that matters is the claims boundary, not the substance. Cosmetic marketing may describe effects on the appearance of expression lines. Drug claims move the product into drug territory whatever the molecule's cosmetic status.

Treating a condition, paralyzing muscle, or matching an injectable neuromodulator's clinical effect are all drug claims. A vendor making botulinum-equivalence claims has crossed that line, and we find it's the same vendors whose documentation falls apart under the identity checks above.

What are the red flags when buying Argireline?

Seven Argireline warning signs we'd walk away from:

• Percentage labels with no mg figure. The cosmetic channel's percent-of-solution convention makes “10% Argireline” ambiguous. Research material states peptide content in milligrams on a CoA. No mg number anywhere means it isn't research-grade documentation.
• Pre-dissolved “research” liquid at powder prices. Dilute cosmetic-grade solution repackaged into small vials is this compound's characteristic grey-market move. Lyophilized powder is the verifiable format.
• Botulinum-equivalence claims. “Topical Botox,” “needle-free Botox results.” The published record shows 10–27% wrinkle-parameter reductions depending on delivery format, not 60–80%+. Equivalence claims misrepresent both mechanism and magnitude.
• Acetyl hexapeptide-3 and -8 listed as different products. Same molecule, renamed in the INCI registry. Two listings at two prices is a catalog integrity failure.
• Mass-spec missing or not near 890.0 [M+H]⁺. A mass near 848 indicates the non-acetylated hexapeptide. Any other significant mismatch means the wrong molecule entirely.
• Missing CAS 616204-22-9 on the CoA. The unique identifier that cuts through the trade-name and INCI-name tangle. Its absence is a documentation gap.
• Single-source documentation. Internal QC isn't sufficient. Third-party ISO 17025 verification is the standard we'd hold a vendor to.

Argireline

10 mg ≥99% pure Lyophilized

Acetylated, amidated hexapeptide, CAS 616204-22-9, sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂. The same reference compound cited across the published SNARE-inhibition and cosmetic dermatology studies. third-party tested; COA with HPLC trace and mass-spec on every lot.

Learn more

Frequently asked questions

Is Argireline legal to buy in the USA?

Yes. Argireline is regulated as a cosmetic ingredient, not a drug. Finished serums sell over the counter, and the raw peptide sells legally as a research reference compound labeled for laboratory use only. It isn't FDA-approved as a drug for any indication and isn't a controlled substance. What isn't legal is selling it under drug claims.

Are acetyl hexapeptide-3 and acetyl hexapeptide-8 the same compound?

Yes. One molecule, one sequence, two generations of INCI naming. The registry designation shifted from acetyl hexapeptide-3 to acetyl hexapeptide-8 and the compound didn't change. CAS 616204-22-9 identifies it unambiguously under either name.

Is Argireline actually “topical Botox”?

No. The analogy is mechanistic shorthand, not equivalence. Both act on SNAP-25's role in the SNARE complex. But botulinum toxin cleaves the protein enzymatically and irreversibly, while Argireline competes with it reversibly, per Megighian et al., 2015. Published controlled results run roughly 10–27% wrinkle-parameter reduction depending on delivery format, versus 60–80%+ for the injectable at treated sites.

What should an Argireline CoA show?

Six things. HPLC purity with the chromatogram. Mass-spec identity near 890.0 for the 889.0 g/mol acetylated amidated hexapeptide. Net peptide content in milligrams. Water content by Karl Fischer titration. Counterion content. CAS 616204-22-9 on the identity line. All of it from an ISO 17025-accredited lab named on the report.

What's the difference between an Argireline research vial and the cosmetic-ingredient version?

Format, documentation, and verifiability. Research-grade is lyophilized powder with a per-lot CoA stating identity and mg content. The cosmetic-ingredient channel sells the same INCI-listed molecule as a dilute bulk solution documented with a spec sheet, where percentage labels describe the solution rather than peptide mass. Both are legitimate in their own lanes. Only one is verifiable as a reference compound.

Why does the delivery vehicle matter so much for Argireline?

Because 889 Da sits well above the 500 Da passive-penetration threshold for intact skin, per Bos and Meinardi, 2000. The published delivery gradient runs about 16% for a topical serum in the controlled trial and about 27% when a microneedle patch bypasses the barrier. It's the clearest natural experiment in the literature on how much the vehicle governs the outcome.

How does Argireline compare to GHK-Cu?

Different mechanisms, different wrinkle types, and a deeper literature for GHK-Cu. Argireline targets dynamic expression-driven lines through neuromuscular signaling. GHK-Cu targets static structural aging through collagen synthesis and dermal-matrix repair, with roughly five decades of academic data. The published formulation literature treats them as complementary rather than interchangeable.